Loading stock data…
Align Technology (ALGN)
$167.01-1.23 (-0.73%)
Market ClosedLast close Jul 24
Align Technology, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Align Technology, Inc. in the Healthcare sector is trading at $167.01 with a market capitalization of $12.8B. Wall Street consensus targets $210.29 (14 analysts), implying a +25.9% move over the next 12 months. The stock is currently 20% below its 52-week high of $208.31, remaining 0.8% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 26 is oversold, raising the odds of a near-term bounce. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +25.9% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Oversold momentum (RSI 26) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.04B↓ | $1.05B↑ | $995.69M↓ | $1.01B↑ | $979.26M |
| Gross Profit | $736.59M↑ | $683.59M↑ | $639.20M↓ | $708.12M↑ | $680.11M |
| Operating Income | $172.59M↑ | $158.88M↑ | $128.13M↓ | $163.03M↑ | $135.28M |
| Net Income | $112.77M↓ | $135.76M↑ | $56.75M↓ | $124.61M↑ | $93.23M |
Peer Comparison
JNJUNHPFE
Fundamentals
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$12.84B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
10.36%
Volume
Today's trading volume
833,483
Recent News
Reasons to Retain Align Technology Stock in Your Portfolio for Now
ALGN's global expansion and iTero innovations support growth, but can they offset currency headwinds and macro pressures?
Align Technology to Report Q2 Earnings: Clear Aligner Segment in Focus
ALGN reports Q2 results on July 29, with investors watching Clear Aligner growth as higher volumes and digital offerings shape quarterly performance.
What Could Reignite Accenture Stock From Here?
While the market frets about near-term headwinds, the consulting giant is quietly deploying billions to buy its next wave of growth.
Cheniere Energy (LNG) Appoints Britt Vitalone As It Reworks Key Credit Lines
Cheniere Energy (NYSE:LNG) has appointed Britt Vitalone, a veteran finance leader with experience at McKesson and Align Technology, to its Board of Directors. Vitalone will serve on both the Audit and Compensation Committees, adding expertise in corporate finance, capital allocation, and governance. The company has also adjusted several revolving credit facilities, including higher commitments, extended maturities, and updated terms for subsidiary credit lines. These governance and credit...
Is This the Right Time to Hold MYGN Stock in Your Portfolio?
Myriad Genetics expands its testing portfolio and advances its Cancer Care Continuum strategy. Can reimbursement risks and cost pressures temper growth?